Skip to main content

New Data: LEGACY Study & IRs During COVID-19

New Data: LEGACY Study & IRs During COVID-19

Dr Osman Ahmed

Osman Ahmed, MD, FCIRSE, Assistant Professor of Vascular and Interventional Radiology at University of Chicago Medicine in Chicago, Illinois, discusses the recently published LEGACY Study, which confirmed Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma. In addition, Dr Ahmed offers his thoughts on interesting new data that demonstrate the strength of Interventional Radiology amidst COVID in comparison with other specialties.

Back to Top